Skip to main content

MARSHALL WACE, LLP

Position in AUTL — Autolus Therapeutics plc

CIK 1318757 LONDON, X0

Position in AUTL

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$151,446
+$114,625 QoQ
Shares Held
94,654
+254.7% QoQ
Ownership
0.036%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#36
of 84 holders
Holding Since
Mar 2020
16 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in AUTL Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

MARSHALL WACE, LLP holds $3,014,740,742 across 267 Biotechnology names. AUTL ranks #249 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in AUTL

Export CSV
16 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $151,446 94,654
2026-03-31 $36,821 26,682
2025-12-31 $537,851 270,277
2025-09-30 $1,046,381 641,952
2025-03-31 $960,864 619,913
2024-12-31 $1,780,207 757,535
2024-09-30 $2,749,852 757,535
2024-06-30 $2,636,221 757,535
2024-03-31 $6,633,139 1,039,677
2023-12-31 $3,200,377 496,953
2023-06-30 $60,680 25,496
2021-12-31 $83,963 16,178
2021-06-30 $1,977,053 297,749
2021-03-31 $567,344 99,013
2020-06-30 $219,162 13,672
2020-03-31 $2,906,521 485,229